<DOC>
	<DOCNO>NCT02387463</DOCNO>
	<brief_summary>The important method slow stop liver disease progression patient chronic hepatitis B antiviral therapy , achieve maintain viral response treatment obtain sustained viral response treatment . The aim therapy interferon make patient obtain immune control HBV , clinical practice , express HBeAg seroconversion , HBsAg loss sustain viral response HBeAg positive patient . However , target ca n't get patient 48 week interferon treatment , patient need extend treatment enhance rate HBeAg seroconversion HBsAg loss . In cohort study , efficacy extend therapy interferon HBeAg positive chronic hepatitis B patient evaluate .</brief_summary>
	<brief_title>Efficacy Extended Peginterferon Alpha 2a Treatment HBeAg Positive Chronic Hepatitis B Patients</brief_title>
	<detailed_description>In cohort study , HBeAg positive chronic hepatitis B patient would treat peginterferon alpha 2a ( PEG-IFN a-2a ) 96 week follow 24 week treatment . Serum HBV DNA load , HBsAg/anti-HBs level , HBeAg/anti-HBe test enrollment every 3 month treatment follow period . Parameters liver kidney function , liver ultrasound examination test interval 1-3 month . The rate HBeAg seroconversion , HBsAg loss , sustain viral response evaluate treatment follow .</detailed_description>
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis A</mesh_term>
	<mesh_term>Hepatitis , Chronic</mesh_term>
	<mesh_term>Hepatitis B</mesh_term>
	<mesh_term>Hepatitis B , Chronic</mesh_term>
	<mesh_term>Peginterferon alfa-2a</mesh_term>
	<mesh_term>Interferon-alpha</mesh_term>
	<criteria>HBeAg positive chronic hepatitis B patient Active consumption alcohol and/or drug Coinfection human immunodeficiency virus , hepatitis C virus , hepatitis D virus History autoimmune hepatitis Psychiatric disease Evidence neoplastic disease liver</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>chronic hepatitis B</keyword>
	<keyword>antiviral therapy</keyword>
	<keyword>peginterferon</keyword>
	<keyword>HBeAg seroconversion</keyword>
	<keyword>HBsAg loss</keyword>
</DOC>